Updated on: 15 July 2020

Roles in: Neonatal Group

1. In the past 36 months have you accepted the following from a commercial organisation with a financial interest in the broad topic area of the Group/Unit?

a) Support for attending meetings, including sabbaticals and study tours (this covers travel, accommodation and/or hospitality)?
No

b) Payment or honoraria for lectures, presentations, speaker bureaus, manuscript writing, or educational events?
Yes - Dr. Zupancic has received honoraria for lecturing for various academic and non-profit organizations, including universities, hospitals, the Vermont Oxford Network and Mednax.

c) Fees for organising education?
No

d) Grants and contracts?
Yes - Dr. Zupancic is a co-investigator on the following grants: 1. Deborah Munroe Noonan Memorial Research Fund Award 2. NHLBI - Transfusions of Preterms Trial (PI: Kirpalani) 3. NIMHD - 1R01MD013969-01A1 - REDUCING DISPARITY IN RECEIPT OF MOTHER’S OWN MILK IN VERY LOW BIRTH WEIGHT INFANTS: AN ECONOMIC INTERVENTION TO IMPROVE ADHERENCE TO SUSTAINED MATERNAL BREAST PUMP USE (Role: consultant, PI: Dr. Aloka Patel) 4. Bill and Melinda Gates Foundation - A Study to Evaluate the Efficacy of Seattle-PAP for the Respiratory Support of Premature Infants (Consultant, subcontract with Nationwide Children’s Hospital; PI: Dr. Carl Backes) 5. NICHD - 1 R01 HD094794-01A1 - Optimizing Family Counseling for Anticipated Extremely Preterm Delivery (Role: Co-Investigator, PI: Dr. Christy Cummings)

e) Funds for a member of staff?
No

f) Fees for consulting?
Yes - Dr. Zupancic has provided consulting services to Sera Prognostics

g) Royalty or licences payments?
No

2. In the past 36 months have you, your spouse/partner or an immediate family member been employed by or do you or they own a commercial organization with a financial interest in the broad topic area of the Group/Unit?
No

3. Do you own stocks or shares in a commercial organization with a financial interest in the broad topic area of the Group/Unit?
No

4. Do you hold any patents (planned, issued or pending) for products relevant to the broad topic area of the Group/Unit?
No

5. Do you have any other competing interests (financial or non-financial)?
No